Generation of mutant human SOD1 knock-in mouse lines at the Rosa26 locus as a platform for developing genome-editing therapies for amyotrophic lateral sclerosis
Experimental Animals · 2026
DOI: 10.1538/expanim.26-0040 ↗Kurz gefasst
Fachartikel in der Zeitschrift Experimental Animals, 2026. Verfasst von Taro Okunomiya und 10 weiteren Autor:innen. Beteiligte Einrichtung: Center for iPS Cell Research and Application (CiRA), Kyoto University.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Center for iPS Cell Research and Application (CiRA), Kyoto University.
Zitieren
APA
Okunomiya, T., Sakasai, T., Tsukita, K., Shimizu, R., Okusa, A., Adachi, M., Tomita, S., Tanaka, A., Kondo, T., Imamura, K., & Inoue, H. (2026). Generation of mutant human SOD1 knock-in mouse lines at the Rosa26 locus as a platform for developing genome-editing therapies for amyotrophic lateral sclerosis. Experimental Animals. https://doi.org/10.1538/expanim.26-0040
Vancouver
Okunomiya T, Sakasai T, Tsukita K, Shimizu R, Okusa A, Adachi M, et al. Generation of mutant human SOD1 knock-in mouse lines at the Rosa26 locus as a platform for developing genome-editing therapies for amyotrophic lateral sclerosis. Experimental Animals. 2026. doi:10.1538/expanim.26-0040
BibTeX
@article{Okunomiya2026,
author = {Okunomiya, Taro and Sakasai, Tomoki and Tsukita, Kayoko and Shimizu, Rina and Okusa, Aya and Adachi, Masahiro and Tomita, Saki and Tanaka, Akito and Kondo, Takayuki and Imamura, Keiko and Inoue, Haruhisa},
title = {Generation of mutant human SOD1 knock-in mouse lines at the Rosa26 locus as a platform for developing genome-editing therapies for amyotrophic lateral sclerosis},
journal = {Experimental Animals},
year = {2026},
doi = {10.1538/expanim.26-0040}
}
EUVIMED